ARVNInvestor•globenewswire•
Arvinas to Participate in Upcoming Investor Conferences
Sentiment:Negative (15)
Summary
(NASDAQ:ARVN) NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will participate in fireside chats at two upcoming investor conferences:
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 29, 2025 by globenewswire